Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common CDKN2A Alteration
帕博西尼治疗对伴有常见 CDKN2A 改变的难治性子宫平滑肌肉瘤的临床获益
期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2016-0310
Elvin, Julia A; Gay, Laurie M; Ort, Rita; Shuluk, Joseph; Long, Jennifer; Shelley, Lauren; Lee, Ronald; Chalmers, Zachary R; Frampton, Garrett M; Ali, Siraj M; Schrock, Alexa B; Miller, Vincent A; Stephens, Philip J; Ross, Jeffrey S; Frank, Richard